Biggest News Aggregation in the World
๐Ÿ“ฐ Elsevier News

Page 78 - Elsevier News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Elsevier. Real-time updates on events, politics, business and more.

Astellas' VEOZAH™ (fezolinetant) Approved by U.S. FDA for Treatment of Vasomotor Symptoms Due to Menopause

 VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause TOKYO, May 12, 2023 /PRNewswire/ -- Astellas Pharma Inc. today... | June 14, 2023
United States Genevieve Neal Perry Naoki Okamura Astellas Pharma Prnewswire Astellas Pharma Inc Health Qual Life Outcomes

Embracing Open Science in a Medical Crisis

Responding to the threat of COVID-19, science advisers from twelve countries have signed on to an open letter urging scientific publishers to make all COVID-19 research freely available to the public through PubMed Central or the World Health Organization's COVID Database.This is an emergency call...
United States Kelvin Droegemeier United States Office Of Science World Health Organization Pubmed Central United States Office
Source: eff.org

Telehealth and Medicine Today Joins Coveted Scopus Index

Telehealth and Medicine Today (THMT) is pleased to announce the open access peer reviewed journal has been accepted to the coveted Scopus index. Owned by Elsevier Inc., Scopus is the largest abstract and citation database of peer-reviewed literature that is used by thousands of academic, government and corporate institutions; designed to serve the information needs of researchers, educators, students, administrators and librarians across the entire global academic community., , , , THMT now.....
United States Elsevier Inc Partners In Digital Health Medicine Today Joins Coveted Scopus Medicine Today Healthcare Device Industry

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Excitatory-inhibitory neurotransmitter imbala

Now, a new study in people with the copy variant number 22q11.2 deletion syndrome (22q11DS) probes the excitatory-inhibitory neurotransmitter system prior to the onset of psychosis. Deletion carriers have a strong predisposition for psychiatric illnesses including anxiety and mood disorders, and they have a 30% lifetime risk of developing psychotic disorders, including schizophrenia, by adulthood. These carriers present a unique opportunity for longitudinal studies on neuropsychiatric illnesses ...
United States Yale New Haven Hospital Yale University John Krystal Johnh Krystal Valentina Mancini

Crud-to-crude: The global potential of biofuels made from human waste

Last year, a car fueled by human waste toured the European countryside, covering more than 2,000 kilometers (1,200 miles). It was the culmination of To-Syn-Fuel, a pathfinding project using technology developed by Germanyโ€™s Fraunhofer Institute UMSICHT to make 50,000 liters (13,200 gallons) of biocrude oil from 500 tons of sewage sludge. The trip marked a […]
United States British Columbia El Salvador Carlos Pozo Jeffrey Cross Laureano Jim

Workers Struggles: Europe, Middle East & Africa

In Italy 30,000 protest against the labour decree that will slash wages, while unions try to suppress general strike calls and promote the Democratic Party; UK stoppages continue over pay and conditions including strikes by ambulance workers, oil and gas offshore workers, civil servants, lecturers and London Heathrow airport staff; doctors walk out for a week at University of Nigeria Teaching Hospital over underfunded health system while civil servants plan walkout in Abia State over unpaid sala...
Brighton And Hove United Kingdom Glasgow City City Of De Unie Northern Cape
Source: wsws.org

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science